Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Brain tumours; Hodgkin's disease, resistant or relapsed; Malignant melanoma; Lung cancer Age: Adult |
Dose: Oral – 100-130 mg/m2 Frequency: as a single dose every 6 weeks Note: Adjust dose according to platelet and leukocyte counts. |
|
Indication: Brain tumours; Hodgkin's disease, resistant or relapsed; Malignant melanoma; Lung cancer Age: Adult Condition: Compromised marrow function |
Dose: Oral – 100 mg/m2 Frequency: as a single dose every 6 weeks |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Brain tumours Age: Child |
Dose: Oral – 75-150 mg/m2 Frequency: as a single dose every 6 weeks Note: Readjust dose according to platelet and leukocyte counts. |
|
Indication: Hodgkin's disease, resistant or relapsed Age: Child |
Dose: Oral – 75-150 mg/m2 Frequency: as a single dose every 6 weeks Note: Readjust dose according to platelet and leukocyte counts. |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment: Creatinine Clearance 10-50 ml/min |
Dose: Dosage – 75% of normal dose Note: Administer 75% of normal dose |
|
Condition: Renal impairment: Creatinine Clearance less than 10 ml/min |
Dose: Dosage – 25-50% of normal dose Note: Administer 25-50% of normal dose |
Administration
- Take on empty stomach
- Take at bedtime
Side Effect
- Nausea (54%)
- Vomiting (54%)
- Neurotoxicity
- Myelosuppression (delayed 4-5 weeks)
- Ataxia
- Lethargy
- Disorientation
- Stomatitis
- Mucositis
- Pulmonary fibrosis (rare)
- Pulmonary toxicity
- Elevated LFTs
- Leukemia
- Renal toxicity
- Hepatic toxicity
- Infertility
- Alopecia
- Optic atrophy (rare)
- Delayed bone marrow suppression and permanent marrow damage following prolonged use
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP2D6 inhibitors
|
Increased levels/effects
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.